Abstract:Abstract Background There have been suggestions of an association between Chlamydia pneumoniae , chlamydial heat shock protein (Ch-hsp) 60 and human heat shock protein (h-hsp) 60 infection sero-status and development of secondary cardiovascular events. Patients with diabetes might be at higher risk since they are prone to infections. The objective of this study was to investigate prospectively the role of Chlamydia pneumoniae (CP), chlamydial heat shock protein (Ch-hsp) 60 and a possible intermediate role of human heat shock protein (h-hsp) 60 sero-status in the development of secondary cardiovascular disease (CVD) events in patients with coronary heart disease (CHD) under special consideration of diabetes mellitus. Methods Patients aged 30–70 undergoing an in-patient rehabilitation program after acute manifestation of coronary heart disease (International Classification of Disease, 9 th Rev. pos. 410–414) between January 1999 and May 2000 in one of two participating rehabilitation clinics in Germany were included in this analysis. Chlamydia pneumoniae (CP), chlamydial heat shock protein (Ch-hsp) 60 and human heat shock protein (h-hsp) 60 status at baseline were measured by serum immunoglobulin G and A antibodies. Secondary CVD events (myocardial infarction, stroke, and cardiovascular death) were recorded during a mean follow-up period of 33.5 months (response = 87%). Results Among the 1052 subjects 37.4% and 39.3% were sero-positive to CP IgA and IgG respectively, 22.2% were sero-positive to Ch-hsp 60 IgG and 8.4% were positive to h-hsp 60 IgG at baseline. During follow-up, secondary CVD events occurred among 71 (6.8%) participants. Occurrence of a secondary CVD event was more common among CP (IgA) and CP (IgG) sero-positive than among sero-negative patients (p-values 0.04 and 0.1, respectively). The risk of secondary CVD events was increased among patients with both a positive CP sero-status and diabetes compared to infection negative, non-diabetic patients and in general, sero-positivity added a hazard to diabetes. The interaction term between infection sero-status and diabetes was not statistically significant. We were not able to show an intermediate role of human heat shock protein (h-hsp) 60 sero-status in the development of secondary CVD events in patients with CHD. Conclusion Results from this cohort of 1052 patients with pre-existing CHD cannot exclude a possible moderate increase in risk of secondary CVD events among patients with a positive infection sero-status. However, our study showed no intermediate role of human heat shock protein (h-hsp) 60 sero-status in the development of secondary CVD events in patients with CHD. Larger studies or meta-analysis of multiple studies are needed to address the interaction between infection sero-status and diabetes with adequate power.

Chlamydia pneumoniae DNA in Peripheral Blood Mononuclear Cells in Healthy Control Subjects and Patients with Diabetes mellitus, Acute Coronary Syndrome, Stroke, and Arterial Hypertension

The Presence of Pneumocystis Jirovecii DNA in Plasma is Associated with a Higher Mortality Rate in Patients with AIDS-associated Pneumocystis Pneumonia

Higher incidence of persistent chronic infection of Chlamydia pneumoniae among coronary artery disease patients in India is a cause of concern

Association Between Chlamydia Pneumonia Infection and Coronary Atherosclerosis in Patients with Diabetes Mellitus Type 2

Infections, Immunity, and Atherosclerosis

Infections, Immunity, And Atherosclerosis - Associations Of Antibodies To Chlamydia Pneumoniae, Helicobacter Pylori, And Cytomegalovirus With Immune Reactions To Heat-Shock Protein 60 And Carotid Or Femoral Atherosclerosis

Chlamydia Pneumoniae Enhanced the Expression of ICAM-1 in Cultured Human Umbilical Vein Endothelial Cells

The Detection of Chlamydia pneumoniae, Helicobacter pylori and Cytomegalovirus in Non-Atherosclerotic Arteries of Patients with Coronary Artery Disease

Chlamydia pneumoniae, heat shock proteins 60 and risk of secondary cardiovascular events in patients with coronary heart disease under special consideration of diabetes: a prospective study

Correlations Between Chlamydophila Pneumoniae, Cytomegalovirus Infection and Carotid Atherosclerotic Plaque and Its Stability

The relationship between chronic obstructive pulmonary disease and Chlamydiae pneumoniae infection]

Detection of serum Chlamydia pneumoniae (Cpn) immune complex and Cpn antibody in patients with coronary heart disease

Chlamydia pneumoniae infection and lung cancer risk: a meta-analysis.

Chronic Chlamydia Pneumoniae Infection is a Risk Factor of COPD

Assessment of Polymerase Chain Reaction and Serology for Detection of Chlamydi a Pneumoniae in Patients with Acute Respiratory Tract Infection

Assessment of evidence for or against contributions of Chlamydia pneumoniae infections to Alzheimer's disease etiology

Effect of Chlamydia pneumoniae infection on coronary flow reserve and intimal hyperplasia after stent implantation in patients with angina pectoris

The relation between chronic chlamydia pneumoniae infection and the ages of coronary heart disease patients

Presence of bacterial DNA in thrombotic material of patients with myocardial infarction

Preliminary clinical study on the association of chlamydia pneumoniae infection and exacerbation of asthma

Chlamydia pneumoniae can infect the central nervous system via the olfactory and trigeminal nerves and contributes to Alzheimer’s disease risk